New fluid strategy could save lives in emergency sepsis surgery

NCT ID NCT07172451

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a balanced gelatin solution is safer and more effective than standard fluids for sepsis patients undergoing emergency abdominal surgery. Sepsis causes fluid loss, leading to low blood pressure and organ damage. The trial will enroll 318 adults and compare fluid balance, blood pressure stability, and kidney function between the two fluids. Results could guide better fluid management in this high-risk group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Balanced gelatin solution (a type of fluid given intravenously to help maintain blood volume)

What this could lead to

If successful, this could show that balanced gelatin is a better fluid for stabilizing blood pressure and reducing fluid overload in septic patients during and after emergency abdominal surgery.

What could go wrong

This is a relatively small, early-phase trial (phase 4) and results may not apply to all sepsis patients. There are also known risks with gelatin solutions, including potential allergic reactions and kidney injury.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Intraabdominal Infections Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affiliated Hospital of Xuzhou Medical University

    NOT_YET_RECRUITING

    Xuzhou, Jiangsu, 221000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The First Affiliated Hospital of Soochow University

    NOT_YET_RECRUITING

    Suzhou, Jiangsu, 215006, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital, Sun Yat-sen University

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510080, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University (WMU)

    NOT_YET_RECRUITING

    Wenzhou, Zhejiang, 325000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The Second Affiliated Hospital, Zhejiang University School of Medicine

    NOT_YET_RECRUITING

    Hangzhou, Zhejiang, 310058, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tianjin Medical University General Hospital

    NOT_YET_RECRUITING

    Tianjing, Tianjing, 300052, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • West China Hospital of Sichuan University

    NOT_YET_RECRUITING

    Chengdu, Sichuan, 610041, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Zhongda Hospital, Southeast University

    NOT_YET_RECRUITING

    Nanjing, Jiangsu, 210009, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Zhongshan Hospital, Fudan University

    RECRUITING

    Shanghai, Shanghai Municipality, 200032, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact